rEVO Biologics gtc-bio.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

rEVO Biologics, fka GTC Biotherapeutics, is a rare disease company focused on developing and delivering therapeutics that are more cost effective to produce than traditional recombinant therapies. Through its rPRO Technology platform, rEVO Biologics is bringing safe and reliable therapeutic proteins to address critical medical needs. The company's lead product, ATryn Antithrombin, is an antithrombin concentrate.

rEVO Biologics, fka GTC Biotherapeutics, is a rare disease company focused on developing and delivering therapeutics that are more cost effective to produce than traditional recombinant therapies. Through its rPRO Technology platform, rEVO Biologics ...Show all

Company (IPO / Went public)

Phone: 508-620-9700

Fax:

175 Crossing Boulevard

Framingham, 01702
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
rEVO Biologics $44M Sep 6, 2005

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related rEVO Biologics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 17 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.